Troxerutin
Indication
1. It is suitable for hemiplegia, aphasia, pre-myocardial infarction syndrome, arteriosclerosis, central retinitis, thrombophlebitis, varicose veins, edema caused by increased vascular permeability, etc. caused by cerebral thrombosis and cerebral embolism; 2. It is suitable for hemiplegia, aphasia, arteriosclerosis, pre-infarction syndrome, thrombophlebitis, varicose veins, chronic venous insufficiency, central retinitis, diabetic retinitis, and edema caused by increased vascular permeability, etc. caused by cerebral thrombosis; 3. Clinical application shows that this product has a wide range of application and good efficacy, especially for the treatment of occlusive cerebrovascular disease.
Manufacturer
Jining Ruixintang Dayu Pharmaceutical Co., Ltd.
-
Founded in:
2022-07-14 -
Address:
188 meters north of the intersection of Dayu North Road and Xi'an Road, Xinyan Town Industrial Park, Yanzhou District, Jining City, Shandong Province -
Tax NO.:
91370882MABU36Q88F -
Registered Funds:
10 million yuan -
Email: